IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 5886 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1
Nancy E. Jones
.2022;()226
[DOI]
2Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
Myrto Lee,Hoan Ly,Clemens C. Möller,Michael S. Ringel
Clinical Pharmacology & Therapeutics.2019;105(4)886
[DOI]
3Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
Katherine Dunnington,Natacha Benrimoh,Christine Brandquist,Nadia Cardillo-Marricco,Mike Di Spirito,Julie Grenier
Clinical Pharmacology & Therapeutics.2018;105(4)886
[DOI]
4The ethical justification for inclusion of neonates in pragmatic randomized clinical trials for emergency newborn care
Dan Kabonge Kaye
BMC Pediatrics.2019;19(1)886
[DOI]
5A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes
Susanna Dodd,Ian R. White,Paula Williamson
Trials.2017;18(1)886
[DOI]
6A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes
Susanna Dodd,Ian R. White,Paula Williamson
Trials.2020;18(1)21
[DOI]
7Commentary on Apathy as a Model for Investigating Behavioral and Psychological Symptoms in Dementia
Andrea Gilmore-Bykovskyi
Journal of the American Geriatrics Society.2018;66(1)S13
[DOI]
8Process evaluation of a randomised controlled trial of PBS-based staff training for challenging behaviour in adults with intellectual disability
Alessandro Bosco,Laura Paulauskaite,Ian Hall,Jason Crabtree,Sujata Soni,Asit Biswas,Vivien Cooper,Michaela Poppe,Michael King,Andre Strydom,Michael J. Crawford,Angela Hassiotis,Rosemary Frey
PLOS ONE.2019;14(8)e0221507
[DOI]
9The benefits of covariate adjustment for adaptive multi-arm designs
Kim May Lee,David S. Robertson,Thomas Jaki,Richard Emsley
Statistical Methods in Medical Research.2022;14(8)096228022211145
[DOI]
10Adaptive trial design: Its growing role in clinical research and implications for pharmacists
Joshua Cirulli,Wesley D. McMillian,Mojdeh Saba,David Stenehjem
American Journal of Health-System Pharmacy.2011;68(9)807
[DOI]
11Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies
Qing Li,Jianchang Lin,Yunzhi Lin
Contemporary Clinical Trials.2020;98(9)106096
[DOI]
12Examining Tensions That Affect the Evaluation of Technology in Health Care: Considerations for System Decision Makers From the Perspective of Industry and Evaluators
Laura Desveaux,James Shaw,Ross Wallace,Onil Bhattacharyya,R Sacha Bhatia,Trevor Jamieson
JMIR Medical Informatics.2017;5(4)e50
[DOI]
13Challenges in Evaluating Safety and Efficacy in Drug Development for Rare Diseases: A Review for Pharmacists
Kanya K. Shah,Stephen Kogut,Angela Slitt
Journal of Pharmacy Practice.2021;34(3)472
[DOI]
14Challenges in Evaluating Safety and Efficacy in Drug Development for Rare Diseases: A Review for Pharmacists
Suresh Kumar
Journal of Pharmacy Practice.2021;34(3)735
[DOI]
15How can attrition rates be reduced in cancer drug discovery?
Lucas Moreno,Andrew DJ Pearson
Expert Opinion on Drug Discovery.2013;8(4)363
[DOI]
16PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints
Tian He,Rachael Liu,Meizi Liu,Jianchang Lin
Journal of Biopharmaceutical Statistics.2022;32(4)567
[DOI]
17Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach
Brian Freed,Brian Williams,Xiaolu Situ,Victoria Landsman,Jeehyoung Kim,Alex Moroz,Heejung Bang,Jongbae J Park
Clinical Trials.2021;18(3)361
[DOI]
18Drug development challenges and strategies to address emerging and resistant fungal pathogens
Matthew W. McCarthy,Thomas J. Walsh
Expert Review of Anti-infective Therapy.2017;15(6)577
[DOI]
19Including non-concurrent control patients in the analysis of platform trials: is it worth it?
Kim May Lee,James Wason
BMC Medical Research Methodology.2020;20(1)577
[DOI]
20Including non-concurrent control patients in the analysis of platform trials: is it worth it?
David Hong,Pedro C. Barata
BMC Medical Research Methodology.2018;20(1)47
[DOI]
21Including non-concurrent control patients in the analysis of platform trials: is it worth it?
Margaret S. Landis
BMC Medical Research Methodology.2017;25(1)297
[DOI]
22Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination
Vikas Rathee,Kapil Pihwal,Neelam Pawar,Sheikh Aamir,Mohammad S. Alam,Kavita Bahmani
Applied Drug Research, Clinical Trials and Regulatory Affairs.2021;8(1)19
[DOI]
23Cardiovascular Nursing Science Priorities
Mariann R. Piano,Nancy T. Artinian,Holli A. DeVon,Susan T. Pressler,Kathleen T. Hickey,Deborah A. Chyun
Journal of Cardiovascular Nursing.2018;33(4)E11
[DOI]
24Adaptive Design of Clinical Trials: A Sequential Learning Approach
Zhengli Wang,Stefanos Zenios
SSRN Electronic Journal.2020;33(4)E11
[DOI]
25Telmisartan to reduce insulin resistance in HIV-positive individuals on combination antiretroviral therapy: the TAILoR dose-ranging Phase II RCT
Sudeep Pushpakom,Ruwanthi Kolamunnage-Dona,Claire Taylor,Terry Foster,Catherine Spowart,Marta Garcia-Finana,Graham J Kemp,Thomas Jaki,Saye Khoo,Paula Williamson,Munir Pirmohamed
Efficacy and Mechanism Evaluation.2019;6(6)1
[DOI]
26Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders
Anuradha Yadav,Brashket Seth,Rajnish Kumar Chaturvedi
The Neuroscientist.2021;27(4)388
[DOI]
27An investigation of the impact of futility analysis in publicly funded trials
Benjamin GO Sully,Steven A Julious,Jon Nicholl
Trials.2014;15(1)388
[DOI]
28Timely evaluation in international development
Jayne Webster,Josephine Exley,James Copestake,Rick Davies,James Hargreaves
Journal of Development Effectiveness.2018;10(4)482
[DOI]
29Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Elliott Antman,Scott Weiss,Joseph Loscalzo
WIREs Systems Biology and Medicine.2012;4(4)367
[DOI]
30Shuffling Adaptive Clinical Trials
Sanjay G. Gokhale,Sankalp Gokhale
American Journal of Therapeutics.2016;23(3)e663
[DOI]
31Computational Drug Repurposing: Current Trends
Berin Karaman,Wolfgang Sippl
Current Medicinal Chemistry.2019;26(28)5389
[DOI]
32Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Miranta Antoniou,Andrea L Jorgensen,Ruwanthi Kolamunnage-Dona,H. Peter Soyer
PLOS ONE.2016;11(2)e0149803
[DOI]
33Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Ruitao Lin,J. Jack Lee
PLOS ONE.2020;11(2)395
[DOI]
34Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Gerfried K.H. Nell
PLOS ONE.2018;11(2)383
[DOI]
35Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective
Elja Arjas,Dario Gasbarra
BMC Medical Research Methodology.2022;22(1)383
[DOI]
36Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective
Peter G. Stock,Rita Mukhtar,Hila Ghersin,Allison Stover Fiscalini,Laura Esserman
BMC Medical Research Methodology.2020;22(1)59
[DOI]
37Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective
Kristiana Salmon,Angela Genge
BMC Medical Research Methodology.2021;22(1)161
[DOI]
38Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective
Sarah J. Trenfield,Christine M. Madla,Abdul W. Basit,Simon Gaisford
BMC Medical Research Methodology.2018;31(1)1
[DOI]
39RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities
Pushya A. Gautama
Journal of Ayurveda and Integrative Medicine.2021;12(3)556
[DOI]
40Adaptive Design: A Review of the Technical, Statistical, and Regulatory Aspects of Implementation in a Clinical Trial
Franck Pires Cerqueira,Angelo Miguel Cardoso Jesus,Maria Dulce Cotrim
Therapeutic Innovation & Regulatory Science.2019;12(3)216847901983124
[DOI]
41Applications of artificial intelligence and machine learning in heart failure
Tauben Averbuch,Kristen Sullivan,Andrew Sauer,Mamas A Mamas,Adriaan A Voors,Chris P Gale,Marco Metra,Neal Ravindra,Harriette G C Van Spall
European Heart Journal - Digital Health.2022;3(2)311
[DOI]
42The Future Role of the United States in Global Health
Valentin Fuster,Jendayi Frazer,Megan Snair,Rajesh Vedanthan,Victor Dzau,Jendayi Frazer,Valentin Fuster,Gisela Abbam,Amie Batson,Frederick Burkle,Lynda Chin,Lia Haskin Fernald,Stephanie Ferguson,Peter Lamptey,Ramanan Laxminarayan,Michael Merson,Vasant Narasimhan,Michael Osterholm,Juan Carlos Puyana
Journal of the American College of Cardiology.2017;70(25)3140
[DOI]
43The Future Role of the United States in Global Health
Zhaoling Meng
Journal of the American College of Cardiology.2022;70(25)169
[DOI]
44Unique Study Designs in Nephrology: N-of-1 Trials and Other Designs
Joyce P. Samuel,Cynthia S. Bell
Advances in Chronic Kidney Disease.2016;23(6)351
[DOI]
45Nutzenbewertung von digitalen Gesundheitsprodukten (Digital Health) im gesellschaftlichen Erstattungskontext
Urs-Vito Albrecht,Bertolt Kuhn,Jörg Land,Volker E. Amelung,Ute von Jan
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.2018;61(3)340
[DOI]
46Implications of comparative effectiveness research for radiation oncology
Justin E. Bekelman,Anand Shah,Stephen M. Hahn
Practical Radiation Oncology.2011;1(2)72
[DOI]
47Implications of comparative effectiveness research for radiation oncology
Gunasakaran Sambandan,Adina Turcu-Stiolica
Practical Radiation Oncology.2019;1(2)323
[DOI]
48Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses
Anna C. Singleton,Rebecca Raeside,Karice K. Hyun,Stephanie R. Partridge,Gian Luca Di Tanna,Nashid Hafiz,Qiang Tu,Justin Tat-Ko,Stephanie Che Mun Sum,Kerry A. Sherman,Elisabeth Elder,Julie Redfern
Journal of Clinical Oncology.2022;40(20)2257
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow